Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells.

[1]  Chunyang Sun,et al.  Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy. , 2015, Biomaterials.

[2]  Li-Hsin Chen,et al.  Autophagy in cancer stem/progenitor cells , 2015, Cancer Chemotherapy and Pharmacology.

[3]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[4]  H. A. Rogoff,et al.  Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.

[5]  S. Singh,et al.  Autophagy in Cancer Stem Cells: A Potential Link Between Chemoresistance, Recurrence, and Metastasis , 2015, BioResearch open access.

[6]  S. Singh,et al.  Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer. , 2014, Biochimica et biophysica acta.

[7]  Lin Mei,et al.  The chemotherapeutic potential of PEG-b-PLGA copolymer micelles that combine chloroquine as autophagy inhibitor and docetaxel as an anti-cancer drug. , 2014, Biomaterials.

[8]  Stephen T C Wong,et al.  Chloroquine Eliminates Cancer Stem Cells Through Deregulation of Jak2 and DNMT1 , 2014, Stem cells.

[9]  M. Hidalgo,et al.  Chloroquine Targets Pancreatic Cancer Stem Cells via Inhibition of CXCR4 and Hedgehog Signaling , 2014, Molecular Cancer Therapeutics.

[10]  Wei Tao,et al.  The effect of autophagy inhibitors on drug delivery using biodegradable polymer nanoparticles in cancer treatment. , 2014, Biomaterials.

[11]  S. Shankar,et al.  Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms , 2013, Molecular Cancer.

[12]  Yuepeng Zhou,et al.  Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells , 2013, Cancer Cell International.

[13]  Alexander V Kabanov,et al.  Can nanomedicines kill cancer stem cells? , 2013, Advanced drug delivery reviews.

[14]  J. Hoheisel,et al.  A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype , 2013, Breast Cancer Research.

[15]  Rong Li,et al.  Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. , 2013, Cancer letters.

[16]  C. Blanpain,et al.  Unravelling cancer stem cell potential , 2013, Nature Reviews Cancer.

[17]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[18]  Ke Chen,et al.  Understanding and targeting cancer stem cells: therapeutic implications and challenges , 2013, Acta Pharmacologica Sinica.

[19]  Xianwei Wang,et al.  Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells. , 2013, Biochemical and biophysical research communications.

[20]  Wei-dong Hu,et al.  Application and interpretation of current autophagy inhibitors and activators , 2013, Acta Pharmacologica Sinica.

[21]  C. Bauvy,et al.  Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance , 2013, Autophagy.

[22]  J. I. Izpisúa Belmonte,et al.  Autophagic control of cell ‘stemness’ , 2013, EMBO molecular medicine.

[23]  S. Ryter,et al.  Autophagy in human health and disease. , 2013, The New England journal of medicine.

[24]  S. Shankar,et al.  Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. , 2012, Biochemical pharmacology.

[25]  C. Gong,et al.  Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells , 2012, Oncogene.

[26]  J. Pedraz,et al.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research , 2012, Clinical and Translational Oncology.

[27]  Wenzhuo Zhuang,et al.  Induction of autophagy promotes differentiation of glioma‐initiating cells and their radiosensitivity , 2011, International journal of cancer.

[28]  N. Mizushima,et al.  The role of Atg proteins in autophagosome formation. , 2011, Annual review of cell and developmental biology.

[29]  K. V. van Golen,et al.  Breast Cancer Stem Cells Survive Periods of Farnesyl-Transferase Inhibitor-Induced Dormancy by Undergoing Autophagy , 2011, Bone marrow research.

[30]  Hans Clevers,et al.  The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.

[31]  Kam W Leong,et al.  Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. , 2011, ACS nano.

[32]  Kevin A Roth,et al.  Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. , 2010, Neuro-oncology.

[33]  Zhenghong Qin,et al.  Autophagy impairment inhibits differentiation of glioma stem/progenitor cells , 2010, Brain Research.

[34]  T. Mikkelsen,et al.  The induction of autophagy by γ‐radiation contributes to the radioresistance of glioma stem cells , 2009, International journal of cancer.

[35]  M. Dyer,et al.  Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. , 2009, The Journal of clinical investigation.

[36]  S. Oh,et al.  Autophagy-Related Proteins, LC3 and Beclin-1, in Placentas From Pregnancies Complicated by Preeclampsia , 2008, Reproductive Sciences.

[37]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer , 2008, Clinical Cancer Research.

[38]  O. Farokhzad,et al.  Nanocarriers as an emerging platform for cancer therapy. , 2007, Nature nanotechnology.

[39]  N. Mizushima,et al.  Autophagy: process and function. , 2007, Genes & development.

[40]  D. Birnbaum,et al.  ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.

[41]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[42]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[43]  Jun Wang,et al.  Nanomedicine-mediated cancer stem cell therapy. , 2016, Biomaterials.

[44]  Xianzhu Yang,et al.  Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells. , 2015, Biomaterials.

[45]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[46]  Jie Yuan,et al.  Supplemental Material to : , 2014 .

[47]  M. Huang,et al.  Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. , 2013, Cancer research.

[48]  Daoqiang Zhang,et al.  A microRNA expression signature characterizing the properties of tumor-initiating cells for breast cancer. , 2012, Oncology letters.

[49]  Luis A. Milla,et al.  Sonic Hedgehog in cancer stem cells: a novel link with autophagy. , 2012, Biological research.

[50]  R. Elble,et al.  The role of cancer stem cells in relapse of solid tumors. , 2012, Frontiers in bioscience.